Source: UNIV OF MARYLAND submitted to NRP
CONTROL MAJOR INFECTIOUS DISEASES OF POULTRY GROWN IN BACKYARD/INTEGRATED FARMS AND IMPROVE PRODUCT SAFETY
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
ACTIVE
Funding Source
Reporting Frequency
Annual
Accession No.
1032400
Grant No.
2024-67023-42502
Cumulative Award Amt.
$648,488.00
Proposal No.
2023-08081
Multistate No.
(N/A)
Project Start Date
Jul 15, 2024
Project End Date
Jul 14, 2027
Grant Year
2024
Program Code
[A1601]- Agriculture Economics and Rural Communities: Small and Medium-Sized Farms
Recipient Organization
UNIV OF MARYLAND
(N/A)
COLLEGE PARK,MD 20742
Performing Department
(N/A)
Non Technical Summary
Currently, the number of traditional small and medium-size backyard and integrated farms are increasing significantly in the US. These farms are commonly antibiotic/chemical-free and produce both crops and livestock in the same facility. Poultry, either broiler or layers, or both, are the common livestock component in these farms. According to recent reports, the mortality rate of poultry grown in antibiotic/chemical-free farms, including backyard and integrated farms, is increased significantly due to various reemerging diseases including coryza. In addition, production efficiency/growth rate of poultry is also a major issue of these farming systems due to the absence of appropriate growth promoters. In this study, we aim to control higher poultry mortality by limiting major infectious diseases specifically infectious coryza, caused by Avibacterium paragallinarum (AP) and its co-infectious agent, infectious bronchitis virus (IBV), and improve production efficiency by adding natural supplements specifically plant phenolic and probiotics in water. To achieve these goals, we propose two major specific aims: 1) Investigate the sources of AP and/or IBV in the farm environment and their transmission routes to chickens, and compare their phenotype and genotype with isolates from clinical specimens collected by clinal labs, and limit their transmission through better farm management; and 2) Evaluate the impact of bioactive probiotic and/or plant-derived phenolics in improving poultry health/immunity and microbiota, and in controlling colonization of AP or AP/IBV using a day-old chick model. This study will develop a strategy to control poultry diseases and improve their growth rate, which will lead to sustainable integrated poultry farming.
Animal Health Component
33%
Research Effort Categories
Basic
33%
Applied
33%
Developmental
34%
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
31132201060100%
Knowledge Area
311 - Animal Diseases;

Subject Of Investigation
3220 - Meat-type chicken, live animal;

Field Of Science
1060 - Biology (whole systems);
Goals / Objectives
The major goals of this study are:1.Investigate the sources of AP and IBV in the farm environment and their transmission routes to chicks, compare their phenotype and genotype with the isolates from clinical specimens, and limit their transmission through better farm management; This broad specific aim has three sub-specific aims:1A: Determine the prevalence of AP and IBV in potential reservoirs in the BF and ICLF environment, and the clinical specimens/carcasses received by the Animal Pathological Laboratory in Eastern Maryland.1B: Determine the relatedness of isolated AP retrieved from various sources and their association to regional and national outbreaks through whole genome sequence analysis.1C: Assess the effectiveness of current biosecurity protocols including cleaning and disinfection and recommend on-farm practice strategies that can reduce transmission of AP/IBV to chicks.2: Evaluate the impact of bioactive probiotic and/or plant-derived phenolics in improving poultry health/immunity through modulating the gut-lung axis to better control colonization of AP or AP/IBV using a day-old chick model.
Project Methods
To determine the prevalence and potential reservoirs of AP and IBV in pasture farms, specifically BFs and ICLFs with poultry components, we will collect approximately 3,600 samples from three selected farms each year for two years. In addition to the farm samples, we will also collect 120 clinical specimens/carcasses per year for two rears which are received by Veterinary Pathology Laboratory in Maryland and determine the prevalence of AP and IBV. Isolation and identification of AP in collected farm samples and the clinical specimens/carcasses will be performed in Dr. Biswas's BSL-2 lab located in the Dept. of ANSC, UMD. Briefly, solid samples will be homogenized and then 1 gm of homogenized samples or 1ml of liquid samples will be enriched in BHI broth with supplement [BBL™ IsoVitaleX™ Enrichment (BD Diagnostics)] as well as serial diluted and directly plated on chocolate agar plate. In addition, genomic DNA will be extracted from all collected samples (both farm samples and clinical specimens) and suspected colonies for AP from culture using the AllPrep DNA/RNA Mini Kit (Qiagen, Valencia, CA) following the manufacturer's recommendations. Confirmation will be performed using PCR using species-specific primers for both AP and IBV. We will also determine the relatedness of isolated AP retrieved from various sources and their association to regional and national outbreaks through using whole genome sequencing.To assess the effectiveness of current biosecurity protocols, we will conduct a professional biosecurity audit of each farm site during the survey using a certified biosecurity auditor. To assess the effectiveness of current cleaning and disinfection protocols at each site, we will use the prevalence of AP and/or IBV in each flock after cleaning and disinfection (before placing the chicks) as measure of cleaning and disinfecting effectiveness. Findings of both assessments will be used to develop on-farm practice strategies/suggestions to address the gaps in biosecurity protocols and improve cleaning and disinfection protocols to reduce contamination in the farm. Finally, we will evaluate the impact of bioactive probiotic and/or plant-derived prebiotics in improving poultry health/immunity and microbiome to control AP or AP/IBV colonization using an artificially challenged chick trials.

Progress 07/15/24 to 07/14/25

Outputs
Target Audience:In this reporting period (1st year), we have reached/communicated with owners and workers of allselected BFs/ICLFs (Backyard Farms/Integrated Crop-livestock farms)and arranged our visiting schedule. To determine theprevalence and potential reservoirs of Avibacterium paragallinarum (AP) and Infectious Bronchitis Virus (IBV) in above mentionedfarmswith poultry components, various farm samples were collected. During thesamples collection and laboratory analysis, all participating students and the postdoctoral fellow were trained for handling biosafety level-2 pathogens. In addition, we also provided primary knowledge of these animal pathogens to the farm workers. Changes/Problems: Nothing Reported What opportunities for training and professional development has the project provided?Two graduate students and a postdoctoral fellow are involved in this project, and they have learned microbiological techniques including culture, molecular analysis of isolation, identification and 16S sequencing, and data analysis. In addition, several undergraduate students were also trained to help graduate students and a postdoctoral fellow/researcher by preparing media, sample preparation and performed DNA isolation. How have the results been disseminated to communities of interest? Nothing Reported What do you plan to do during the next reporting period to accomplish the goals?We are planning to continuethe farm visit and collect more farmsamples for microbiological and molecular analysis for confirmation of the targeted pathogens and determine the sources of the pathogens. We will also keep collecting clinical samples from the clinical laboratory ofMaryland Veterinary Division. We will alsocomparethecolonization or infection withAvibacterium paragallinarum(AP)and/or Infectious Bronchitis Virus (IBV)in chicks of ICLFs determining theproperties of isolated pathogensusing16S sequencing. We are also aiming to perform poultrytrials using our probiotic or prebiotic or their combination. We are also planning to analyze our data and prepare the manuscripts.

Impacts
What was accomplished under these goals? To achieve the goal -1, we visited each selected farm siteseveraltimes of a single production cycle and collected samples including chick delivery-box paper liners (if it is available), nasal swab, fecal, floor, feed water, open ground, grass, fecal from wild birds, animal and rodent, flies etc.Water samples werecollected: one from the tank and another from the final dispenser lines. Surface/floor swabs werecollected from the interior or exterior sides of the house with sterile wet gauze pads and disinfectant neutralizers. Each indoor and outdoor environmental samples werecollected from areas around or on the ventilation fans. Feed samples werecollected directly from trucks every time a new truck load arrives at the farm.We collected the samples aseptically and in sterilized plastic bags and carried them to the lab using ice containing cool box. In the lab, we have performed microbiology culture and selected the presumptive position colonies for further culture and molecular confirmation. Solid samples werehomogenized at the laboratory before evaluating forAvibacterium paragallinarum(AP)isolation by culture and PCR detection for both AP andInfectious Bronchitis Virus (IBV). Our collaborator, Maryland Veterinary Doctor, also provided clinical samples which were positive with either AP or IBV or both.All samples wereenriched in BHI broth with supplementas well as serial diluted and directly plated on chocolate agar plate.Genomic DNA wasextracted from all collected samples (both farm samples and clinical specimens) and suspected colonies for AP from culture using the AllPrep DNA/RNA Mini Kit (Qiagen, Valencia, CA) following the manufacturer's recommendations.Simultaneously, we havealso preparedthe poultry trials usingour developed probiotic,prebiotic and their combination in preventing AP or IBV infections.

Publications